Taken together, these data demonstrate that SEMA4A is associated with both activated and GC B cells in tonsil and the TME of patients with HNSCC, ultimately marking TLS with GC in HPV+ patients due to its strong correlation with BCL6 expression. The gene discussed is SEMA4A; the disease is head and neck squamous cell carcinoma.